Search Results 961-970 of 15347 for alt

1. Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND) - Mayo Clinic

   Alanine transaminase (ALT): >2x upper limit of normal (ULN) at screening. Bilirubin: >1.5xULN at screening. Current unstable liver or biliary disease per ...

2. (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive - Mayo Clinic

   Serum aspartate transaminase (AST) and/or alanine transaminase (ALT) ≤2.5×ULN. Exclusion Criteria: Acute Promyelocytic Leukemia (AML subtype M3). AML ...

3. A Comparative Effectiveness Study Of Major Glycemia-lowering Medications For Treatment Of Type 2 Diabetes - Mayo Clinic

   History of severe liver disease or acute hepatitis or ALT > 3 times upper limit of normal; Current alcoholism or excessive alcohol intake; Previous organ ...

4. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) - Mayo Clinic

   ... ALT < 3 × ULN that are not attributable to HBV infection), and are willing to start and maintain antiviral treatment for the duration of the study, are allowed.

5. A Study of Sporadic Angiomyolipomas Growth Kinetics While on Everolimus - Mayo Clinic

   Aspartate aminotransferase (AST) / alanine transaminase (ALT) ≤ 2.5 X ULN; Total bilirubin ≤ 2.0mg/dL; Renal Function epidermal growth factor receptor (eGFR) ...

6. A Study of TAS-120 in Patients With Metastatic Breast Cancer - Mayo Clinic

   ... ALT ≤ 5 × ULN;; Total bilirubin ≤ 1.5 × ULN or ≤ 3 × ULN in case of Gilbert's syndrome;; Absolute neutrophil count (ANC) ≥ 1.0 × 10^9/L without ...

7. Mechanisms of Anabolic Resistance in Older Humans - Mayo Clinic

   Chronic active liver disease (AST > 144IU/L or ALT > 165IU/L); Oral warfarin group medications or history of blood clotting disorders. Smoking. Pregnancy or ...

8. Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... ALT ≤ 2.5 times ULN is acceptable; Estimated creatinine clearance of ≥ 30 mL/min, calculated using the formula of Cockroft and Gault; Female patients of ...

9. TAS-102 in Treating Advanced Biliary Tract Cancers - Mayo Clinic

   Aspartate transaminase (AST) or alanine transaminase (ALT) =< 3 x ULN; Creatinine =< 1.5 x ULN; Negative pregnancy test done =< 7 days prior to registration ...

10. A Study Evaluating Temozolomide vs. Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma - Mayo Clinic

    AST/ALT ≤ 3.0 x ULN;; Creatinine < 1.5 x ULN OR Calc. Creatinine Clearance > 50 mL/min.***. *. In the absence of transfusion within the previous 24 hours ...